Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740595 · ClinicalTrials.gov registry record · NA
E-cigarettes and Blood Vessel Function
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT02740595 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 148 participants.
The verdict
NCT02740595, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, and sham control, on endothelial function and markers of oxidative stress.
Interventions
- OTHER one time exposure to e-cig with nicotine
- OTHER one time exposure to e-cig without nicotine
- OTHER one time exposure to empty e-cig
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2015-08 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02740595
The ClinicalTrials.gov registry entry for NCT02740595 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which one time exposure to e-cig with nicotine is the first listed.
NCT02740595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02740595 about?
NCT02740595 is a clinical study titled "E-cigarettes and Blood Vessel Function". Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, and sham control, on endothelial function and markers of oxidative stress.
What is the current status of trial NCT02740595?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2015-08. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT02740595?
The interventions under investigation include: one time exposure to e-cig with nicotine (OTHER), one time exposure to e-cig without nicotine (OTHER), one time exposure to empty e-cig (OTHER).
Who is sponsoring clinical trial NCT02740595?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.